Log in to save to my catalogue

Effective use of dupilumab for eosinophilic gastritis concomitant with severe asthma

Effective use of dupilumab for eosinophilic gastritis concomitant with severe asthma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e99174ac1a71478594cfebd97b04e78b

Effective use of dupilumab for eosinophilic gastritis concomitant with severe asthma

About this item

Full title

Effective use of dupilumab for eosinophilic gastritis concomitant with severe asthma

Publisher

England: BioMed Central Ltd

Journal title

Allergy, asthma, and clinical immunology, 2024-12, Vol.20 (1), p.68-7, Article 68

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Eosinophilic gastrointestinal diseases (EGIDs) are chronic immune-mediated inflammatory disorders characterized by gastrointestinal symptoms and eosinophilic inflammation in specific regions of the gastrointestinal tract. "Eosinophilic gastritis" (EoG) refers to the condition in which the stomach is involved. In patients with EoG, approved treatmen...

Alternative Titles

Full title

Effective use of dupilumab for eosinophilic gastritis concomitant with severe asthma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e99174ac1a71478594cfebd97b04e78b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e99174ac1a71478594cfebd97b04e78b

Other Identifiers

ISSN

1710-1484,1710-1492

E-ISSN

1710-1492

DOI

10.1186/s13223-024-00940-5

How to access this item